Business Operations Contracts & Agreements in the Biotechnology Industry

5,253 Contracts & Agreements

Browse by Subcategory

Administration Agreements (8 contracts from 5 companies)
Advisory Agreements (74 | 37)
Agency Agreements (282 | 128)
Code of Ethics (8 | 5)
Collaboration Agreements (1,217 | 301)
Cooperation Agreements (33 | 27)
Development Agreements (609 | 164)
Distribution Agreements (84 | 37)
Indemnification Agreements (643 | 401)
Management Agreements (115 | 60)
Marketing Agreements (23 | 16)
MOUs (28 | 20)
Operating Agreements (11 | 7)
Proxy Agreements (3 | 3)
Sales Agreements (449 | 244)
Services Agreements (672 | 245)
Settlement Agreements (195 | 117)
Supply Agreements (409 | 151)
Termination Agreements (206 | 135)
Voting Agreements (184 | 99)

Browse by Company

2seventy bio, Inc. (4 contracts)
4D Molecular Therapeutics Inc (5)
89bio, Inc. (5)
AbbVie Inc. (4)
ABEONA THERAPEUTICS INC. (3)
ACADIA PHARMACEUTICALS INC (21)
ACCELERON PHARMA INC (6)
Accustem Sciences Inc. (2)
Achaogen, Inc. (5)
ACHIEVE LIFE SCIENCES, INC. (12)
Acorda Therapeutics (25)
Actinium Pharmaceuticals, Inc. (7)
Acumen Pharmaceuticals, Inc. (4)
Acurx Pharmaceuticals, LLC (3)
Adagio Therapeutics, Inc. (8)
Adamas Pharmaceuticals Inc (3)
Adaptimmune Therapeutics PLC (16)
Adhera Therapeutics, Inc. (7)
ADiTx Therapeutics, Inc. (4)
ADMA BIOLOGICS, INC. (12)
ADURO BIOTECH, INC. (9)
Advaxis, Inc. (16)
Adverum Biotechnologies, Inc. (12)
Aeglea BioTherapeutics, Inc. (14)
Aerovate Therapeutics, Inc. (3)
AGENUS INC (14)
AgeX Therapeutics, Inc. (1)
AGIOS PHARMACEUTICALS INC (2)
AILERON THERAPEUTICS INC (2)
Aimmune Therapeutics, Inc. (7)
AKCEA THERAPEUTICS, INC. (9)
Akebia Therapeutics, Inc. (29)
Akero Therapeutics, Inc. (1)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (13)
Aldeyra Therapeutics, Inc. (1)
Alector, Inc. (6)
Alexion Pharmaceuticals (8)
Aligos Therapeutics, Inc. (1)
Alkermes plc. (16)
Allakos Inc. (9)
Allarity Therapeutics, Inc. (7)
Allena Pharmaceuticals, Inc. (3)
Alliqua BioMedical, Inc. (15)
Allogene Therapeutics, Inc. (9)
Allovir, Inc. (6)
ALNYLAM PHARMACEUTICALS, INC. (34)
Alpha Healthcare Acquisition Corp. (6)
ALPINE IMMUNE SCIENCES, INC. (3)
Altimmune, Inc. (13)
ALX ONCOLOGY HOLDINGS INC (3)
Alzamend Neuro, Inc. (2)
AMARILLO BIOSCIENCES INC (10)
AMARIN CORP PLC (13)
Amgen Inc. (26)
AMICUS THERAPEUTICS, INC. (21)
AmpliPhi Biosciences Corp (15)
Amplitude Healthcare Acquisition Corp (3)
ANAPTYSBIO INC (6)
ANAVEX LIFE SCIENCES CORP. (15)
Anchiano Therapeutics Ltd. (1)
Anika Therapeutics (4)
Anixa Biosciences Inc (11)
Annexon, Inc. (2)
Annovis Bio, Inc. (2)
Apellis Pharmaceuticals, Inc. (6)
APPLIED GENETIC TECHNOLOGIES CORP (2)
Applied Molecular Transport Inc. (3)
Applied Therapeutics Inc. (1)
Aprea Therapeutics, Inc. (5)
Aptevo Therapeutics Inc. (15)
Aptinyx Inc. (2)
Aptose Biosciences Inc. (2)
AquaBounty Technologies, Inc. (3)
AQUINOX PHARMACEUTICALS, INC (6)
Aravive, Inc. (11)
Arbutus Biopharma Corp (3)
ARCA biopharma, Inc. (35)
Arcellx, Inc. (3)
Arcturus Therapeutics Holdings Inc. (12)
Arcus Biosciences, Inc. (5)
Arcutis Biotherapeutics, Inc. (5)
ARDELYX, INC. (10)
ARENA PHARMACEUTICALS INC (18)
Aridis Pharmaceuticals, Inc. (2)
ARROWHEAD PHARMACEUTICALS, INC. (4)
Arsanis, Inc. (13)
Artiva Biotherapeutics, Inc. (11)
ARYA Sciences Acquisition Corp II (4)
ASSEMBLY BIOSCIENCES, INC. (5)
Atara Biotherapeutics, Inc. (26)
Athenex, Inc. (13)
ATHERSYS, INC (63)
ATOSSA GENETICS INC (9)
Atreca, Inc. (1)
aTYR PHARMA INC (3)
Aura Biosciences, Inc. (1)
Aurinia Pharmaceuticals Inc. (5)
AVEO PHARMACEUTICALS INC (11)
Avid Bioservices, Inc. (5)
Avidity Biosciences, Inc. (5)
Avita Therapeutics, Inc. (4)
AVROBIO, Inc. (3)
Axcella Health Inc. (3)
Axovant Sciences Ltd. (15)
Ayala Pharmaceuticals, Inc. (3)
AZIYO BIOLOGICS, INC. (5)
AzurRx BioPharma, Inc. (8)
BCTG Acquisition Corp. (2)
Beam Therapeutics Inc. (4)
BeiGene, Ltd. (11)
BELLICUM PHARMACEUTICALS, INC (4)
Benitec Biopharma Inc. (5)
BICYCLE THERAPEUTICS Ltd (20)
Big Cypress Acquisition Corp. (4)
BIO-PATH HOLDINGS INC (7)
bioAffinity Technologies, Inc. (9)
BioAtla, Inc. (7)
BioCardia, Inc. (11)
BIOCEPT INC (19)
BIOCRYST PHARMACEUTICALS INC (21)
Biogen Inc. (8)
Biohaven Pharmaceutical Holding Co Ltd. (3)
BioLife4D Corp (15)
BIOMARIN PHARMACEUTICAL INC (12)
Biomea Fusion, Inc. (2)
BioNexus Gene Lab Coporation (2)
BioRestorative Therapies, Inc. (3)
BIOSPECIFICS TECHNOLOGIES CORP (5)
Biostage, Inc. (7)
BIOTIME INC (11)
BIOVIE INC. (1)
BioXcel Therapeutics, Inc. (3)
BIOXYTRAN, INC (7)
Bison Capital Acquisition Corp. (6)
Black Diamond Therapeutics, Inc. (4)
Blue Water Vaccines Inc. (12)
bluebird bio, Inc. (21)
Blueprint Medicines Corp (15)
Bolt Biotherapeutics, Inc. (4)
Bone Biologics Corp (7)
BRAINSTORM CELL THERAPEUTICS INC. (9)
BriaCell Therapeutics Corp. (5)
BridgeBio Pharma, Inc. (5)
BullFrog AI Holdings, Inc. (3)
C4 Therapeutics, Inc. (5)
Cabaletta Bio, Inc. (11)
CALADRIUS BIOSCIENCES, INC. (10)
Calithera Biosciences, Inc. (3)
Calyxt, Inc. (8)
CANCER GENETICS, INC (4)
Candel Therapeutics, Inc. (1)
CAPRICOR THERAPEUTICS, INC. (9)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (6)
Capstone Therapeutics Corp. (19)
CareDx, Inc. (3)
Caribou Biosciences, Inc. (25)
CASI Pharmaceuticals, Inc. (6)
CASTLE BIOSCIENCES INC (2)
Castle Creek Biosciences, Inc. (5)
CATABASIS PHARMACEUTICALS INC (3)
CATALYST BIOSCIENCES, INC. (25)
CATALYST PHARMACEUTICALS, INC. (5)
CEL SCI CORP (2)
Celcuity Inc. (2)
Cell Source, Inc. (4)
Celldex Therapeutics, Inc. (15)
Cellectar Biosciences, Inc. (5)
Cellular Biomedicine Group, Inc. (4)
Celsion CORP (10)
Centessa Pharmaceuticals Ltd (1)
Century Therapeutics, Inc. (9)
CEREBAIN BIOTECH CORP. (3)
Chanticleer Holdings, Inc. (5)
Chardan Healthcare Acquisition 2 Corp. (2)
Chardan Healthcare Acquisition Corp. (10)
Checkmate Pharmaceuticals, Inc. (3)
Checkpoint Therapeutics, Inc. (6)
Chelsea Worldwide Inc. (3)
ChemoCentryx, Inc. (15)
CHIMERIX INC (31)
Cibus Global, Ltd. (2)
Cidara Therapeutics, Inc. (3)
CLEVELAND BIOLABS INC (7)
Clovis Oncology, Inc. (18)
CM Life Sciences III Inc. (2)
Codiak BioSciences, Inc. (5)
CohBar, Inc. (4)
Coherus BioSciences, Inc. (9)
Comera Life Sciences Holdings, Inc. (2)
COMPASS Pathways plc (3)
Conatus Pharmaceuticals Inc. (14)
CONCERT PHARMACEUTICALS, INC. (2)
Consonance-HFW Acquisition Corp. (5)
Constellation Alpha Capital Corp. (6)
CONSTELLATION PHARMACEUTICALS INC (4)
CONTRAFECT Corp (5)
Corbus Pharmaceuticals Holdings, Inc. (2)
Cortexyme, Inc. (1)
Corvus Pharmaceuticals, Inc. (4)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (5)
Crinetics Pharmaceuticals, Inc. (2)
CRISPR Therapeutics AG (12)
CTD HOLDINGS INC (3)
CTI BIOPHARMA CORP (22)
Cue Biopharma, Inc. (20)
Cullinan Oncology, LLC (9)
Curative Biotechnology Inc (6)
CURIS INC (15)
Cyclacel Pharmaceuticals, Inc. (15)
Cyclerion Therapeutics, Inc. (2)
CytoDyn Inc. (21)
Cytokinetics, Incorporated (27)
CytomX Therapeutics, Inc. (19)
CYTORI THERAPEUTICS, INC. (10)
CYTRX CORP (10)
Day One Biopharmaceuticals Holding Co LLC (1)
DBV Technologies S.A. (2)
Decibel Therapeutics, Inc. (2)
Deciphera Pharmaceuticals, Inc. (4)
DelMar Pharmaceuticals, Inc. (10)
Denali Therapeutics Inc. (13)
Dermavant Sciences Ltd (6)
DiaMedica Therapeutics Inc. (14)
Dicerna Pharmaceuticals Inc (12)
Diffusion Pharmaceuticals Inc. (16)
Digital Development Partners, Inc. (6)
DYADIC INTERNATIONAL INC (7)
Dynamics Special Purpose Corp. (7)
DYNAVAX TECHNOLOGIES CORP (20)
Dyne Therapeutics, Inc. (1)
Eagle Pharmaceuticals, Inc. (13)
Edge Therapeutics, Inc. (8)
Editas Medicine, Inc. (7)
Eidos Therapeutics, Inc. (4)
Eiger BioPharmaceuticals, Inc. (9)
Elevation Oncology, Inc. (3)
Eliem Therapeutics, Inc. (2)
Emerald Bioscience, Inc. (9)
Emergent BioSolutions Inc. (31)
Enanta Pharmaceuticals, Inc. (1)
ENDONOVO THERAPEUTICS, INC. (1)
Enochian Biosciences Inc (7)
Entasis Therapeutics Holdings Inc. (4)
Entera Bio Ltd. (2)
Entrada Therapeutics, Inc. (8)
Environmental Impact Acquisition Corp (2)
ENZON PHARMACEUTICALS, INC. (10)
Epizyme, Inc. (13)
Equillium, Inc. (8)
Erasca, Inc. (2)
Esperion Therapeutics, Inc. (15)
Evelo Biosciences, Inc. (7)
EVOLUTIONARY GENOMICS, INC. (2)
EXACT SCIENCES CORP (2)
Exelixis (63)
EXICURE, INC. (5)
FATE THERAPEUTICS INC (7)
FENNEC PHARMACEUTICALS INC. (5)
Fibrocell Science, Inc. (5)
FIBROGEN INC (27)
FIVE PRIME THERAPEUTICS INC (24)
Flex Pharma, Inc. (7)
Flexion Therapeutics Inc (11)
Foghorn Therapeutics Inc. (4)
Forma Therapeutics Holdings, Inc., (2)
Fortress Biotech, Inc. (10)
Forty Seven, Inc. (7)
Frequency Therapeutics, Inc. (5)
FS Development Corp. (16)
FS Development Corp. II (9)
Fusion Pharmaceuticals Inc. (9)
G1 Therapeutics, Inc. (5)
Gain Therapeutics, Inc. (4)
GALECTIN THERAPEUTICS INC (7)
Galecto Inc. (3)
Galera Therapeutics, Inc. (3)
Gamida Cell Ltd. (3)
Gemphire Therapeutics Inc. (7)
Gene Biotherapeutics, Inc. (3)
GENELUX CORP (1)
Generation Bio Co. (2)
GENEREX BIOTECHNOLOGY CORP (8)
GENETHERA INC (1)
GENOCEA BIOSCIENCES, INC. (2)
Genprex, Inc. (7)
GeoVax Labs, Inc. (5)
GERON CORP (6)
Gilead Sciences (11)
Global Blood Therapeutics, Inc. (2)
GLYCOMIMETICS INC (5)
Gossamer Bio, Inc. (2)
Grail, Inc. (2)
Graphite Bio, Inc. (1)
Greater Cannabis Company, Inc. (6)
Greenwich LifeSciences, Inc. (1)
Gritstone Oncology, Inc. (5)
GT Biopharma, Inc. (16)
GTX INC (40)
GX Acquisition Corp. (11)
HALOZYME THERAPEUTICS INC (1)
HARBOR DIVERSIFIED, INC. (1)
Harpoon Therapeutics, Inc. (10)
HCW Biologics Inc. (5)
Health Sciences Acquisitions Corp (10)
HEAT BIOLOGICS, INC. (14)
HedgePath Pharmaceuticals, Inc. (3)
HEMISPHERX BIOPHARMA INC (19)
HERON THERAPEUTICS, INC. (5)
HilleVax, Inc. (2)
Hillstream BioPharma Inc. (2)
HISTOGENICS CORP (13)
Homology Medicines, Inc. (11)
HOOKIPA Pharma Inc. (6)
HUMANIGEN, INC (11)
iBio, Inc. (13)
Icosavax, Inc. (1)
IDEAYA Biosciences, Inc. (16)
IDERA PHARMACEUTICALS, INC. (13)
IGM Biosciences, Inc. (2)
Imago BioSciences, Inc. (1)
Immix Biopharma, Inc. (8)
IMMUCELL CORP (1)
IMMUNE PHARMACEUTICALS INC (8)
Immune Therapeutics, Inc. (16)
Immuneering Corp (3)
ImmunoCellular Therapeutics, Ltd. (8)
IMMUNOGEN INC (11)
Immunome Inc. (4)
IMMUNOMEDICS INC (13)
Incyte (7)
INFINITY PHARMACEUTICALS, INC. (7)
Inhibikase Therapeutics, Inc. (7)
Inhibrx, Inc. (7)
InMed Pharmaceuticals Inc. (2)
Inmune Bio, Inc. (11)
Innovation Pharmaceuticals Inc. (2)
INOVIO PHARMACEUTICALS, INC. (16)
Inozyme Pharma, Inc. (1)
INSMED Inc (10)
Inspyr Therapeutics, Inc. (4)
Instil Bio, Inc. (1)
Intec Parent Inc. (2)
Intec Pharma Ltd. (2)
Intellia Therapeutics, Inc. (7)
INTERCEPT PHARMACEUTICALS, INC. (16)
International Stem Cell CORP (3)
INTREXON CORP (23)
Intrinsic Medicine, Inc. (1)
Invitae Corp (5)
IO Biotech, Inc. (8)
IONIS PHARMACEUTICALS INC (40)
IOVANCE BIOTHERAPEUTICS, INC. (7)
IRONWOOD PHARMACEUTICALS INC (8)
Isoray, Inc. (28)
iTeos Therapeutics, Inc. (5)
Janux Therapeutics, Inc. (2)
Jounce Therapeutics, Inc. (3)
Kadmon Holdings, Inc. (2)
KalVista Pharmaceuticals, Inc. (5)
Karuna Therapeutics, Inc. (3)
Karyopharm Therapeutics Inc. (4)
KBL MERGER CORP. IV (9)
Keros Therapeutics, Inc. (2)
Kezar Life Sciences, Inc. (3)
Kindred Biosciences, Inc. (10)
Kiniksa Pharmaceuticals, Ltd. (2)
Kinnate Biopharma Inc. (1)
Kiromic Biopharma, Inc. (9)
KIWA BIO-TECH PRODUCTS GROUP CORP (2)
Kodiak Sciences Inc. (1)
Kronos Bio, Inc. (1)
Krystal Biotech, Inc. (4)
Kura Oncology, Inc. (13)
Kymera Therapeutics, Inc. (5)
LA JOLLA PHARMACEUTICAL CO (3)
Lantern Pharma Inc. (3)
LEAP THERAPEUTICS, INC. (7)
Leisure Acquisition Corp. (18)
LEXICON PHARMACEUTICALS, INC. (13)
LianBio (11)
LifeSci Acquisition Corp. (4)
Ligand Pharmaceuticals Incorporated (22)
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (12)
Locust Walk Acquisition Corp. (3)
LogicBio Therapeutics, Inc. (3)
LONGEVERON LLC (4)
Lyell Immunopharma, Inc. (4)
MACROGENICS INC (11)
MADRIGAL PHARMACEUTICALS, INC. (14)
Magenta Therapeutics, Inc. (14)
MAIA Biotechnology, Inc. (3)
MANHATTAN SCIENTIFICS INC (1)
MANNKIND CORP (22)
MARIZYME INC (17)
Marker Therapeutics, Inc. (6)
MATEON THERAPEUTICS INC (15)
Matinas BioPharma Holdings, Inc. (4)
MAXCYTE, INC. (1)
MEDICINOVA INC (7)
Medovex Corp. (5)
MEI Pharma, Inc. (10)
MeiraGTx Holdings plc (4)
MERRIMACK PHARMACEUTICALS INC (2)
Mersana Therapeutics, Inc. (21)
Merus N.V. (4)
Millendo Therapeutics, Inc. (3)
MiMedx Group, Inc. (6)
Minerva Neurosciences, Inc. (3)
MiNK Therapeutics, Inc. (3)
MIRAGEN THERAPEUTICS, INC. (16)
Mirati Therapeutics, Inc. (5)
Mirum Pharmaceuticals, Inc. (2)
Moderna, Inc. (10)
Molecular Templates, Inc. (14)
Moleculin Biotech, Inc. (13)
Momenta Pharmaceuticals, Inc. (9)
Monopar Therapeutics (1)
Monte Rosa Therapeutics, Inc. (6)
Morphic Holding, Inc. (9)
MUSTANG BIO, INC. (9)
MYMETICS CORP (3)
Myovant Sciences Ltd. (20)
Myriad Genetics, Inc. (5)
NANOVIRICIDES, INC. (5)
NantKwest, Inc. (16)
Natera, Inc. (13)
NAVIDEA BIOPHARMACEUTICALS, INC. (8)
NEUROBIOLOGICAL TECHNOLOGIES INC (9)
NEUROCRINE BIOSCIENCES INC (10)
NEUROTROPE BIOSCIENCE, INC. (7)
Neurotrope, Inc. (10)
NEWLINK GENETICS CORP (39)
NexImmune, Inc. (2)
NextCure, Inc. (4)
Nkarta, Inc. (6)
NORTHWEST BIOTHERAPEUTICS INC (14)
NOVAVAX INC (34)
Novus Therapeutics, Inc. (7)
NTN BUZZTIME INC (14)
Nuo Therapeutics, Inc. (5)
Nurix Therapeutics, Inc. (10)
NUTRA PHARMA CORP (1)
Nuvalent, Inc. (3)
Ohr Pharmaceutical Inc (1)
Olema Pharmaceuticals, Inc. (8)
Olivia Ventures, Inc. (5)
Omega Therapeutics, Inc. (5)
OncBioMune Pharmaceuticals, Inc (5)
OncoCyte Corp (6)
Oncorus, Inc. (1)
ONCOSEC MEDICAL Inc (16)
OPGEN INC (3)
Ophthotech Corp. (2)
Opko Health, Inc. (10)
ORAGENICS INC (14)
Orchard Therapeutics plc (5)
Organicell Regenerative Medicine, Inc. (3)
Organogenesis Holdings Inc. (6)
ORGANOVO HOLDINGS, INC. (7)
Orgenesis Inc. (15)
Oric Pharmaceuticals, Inc. (3)
Outlook Therapeutics, Inc. (6)
Ovid Therapeutics Inc. (4)
Oyster Point Pharma, Inc. (1)
PALATIN TECHNOLOGIES INC (8)
Pasithea Therapeutics Corp. (6)
Passage BIO, Inc. (17)
PDL BIOPHARMA, INC. (9)
PepGen Inc. (3)
Petra Acquisition Inc. (13)
Pfenex Inc. (6)
PharmaCyte Biotech, Inc. (9)
PhaseBio Pharmaceuticals Inc (5)
Phio Pharmaceuticals Corp. (2)
PIERIS PHARMACEUTICALS, INC. (29)
PLURISTEM THERAPEUTICS INC (19)
PMV Pharmaceuticals, Inc. (1)
POLARITYTE, INC. (8)
PORTOLA PHARMACEUTICALS INC (8)
Poseida Therapeutics, Inc. (5)
Praxis Precision Medicines, Inc. (4)
PRECISION BIOSCIENCES INC (5)
PREDICTIVE TECHNOLOGY GROUP, INC. (2)
Principia Biopharma Inc. (1)
Progenics Pharmaceuticals, Inc. (4)
PROGENITY, INC. (25)
Prometheus Biosciences, Inc. (2)
ProMIS Neurosciences Inc. (5)
Propanc Biopharma, Inc. (9)
Protagenic Therapeutics, Inc. (7)
Protagonist Therapeutics, Inc (7)
Protalix BioTherapeutics, Inc. (3)
PROTEON THERAPEUTICS INC (26)
PROTEOSTASIS THERAPEUTICS, INC. (15)
Prothena Corp plc (6)
ProtoKinetix, Inc. (1)
PTC THERAPEUTICS, INC. (8)
PUMA BIOTECHNOLOGY, INC. (4)
Pyxis Oncology, Inc. (2)
Q BioMed Inc. (5)
Qrons Inc. (9)
Radius Health, Inc. (33)
Rallybio Corp (3)
RAPT Therapeutics, Inc. (5)
RECURSION PHARMACEUTICALS, INC. (8)
Regeneron Pharmaceuticals (34)
REGENERX BIOPHARMACEUTICALS INC (1)
REGENXBIO Inc. (7)
Regulus Therapeutics Inc. (5)
Relay Therapeutics, Inc. (5)
Reneo Pharmaceuticals, Inc. (2)
RenovaCare, Inc. (2)
RenovoRx, Inc. (4)
Repare Therapeutics Inc. (11)
Replimune Group, Inc. (2)
Retrophin, Inc. (7)
Revolution Medicines, Inc. (6)
REXAHN PHARMACEUTICALS, INC. (13)
Rezolute, Inc. (8)
RHYTHM PHARMACEUTICALS, INC. (8)
Rich Pharmaceuticals, Inc. (2)
RIGEL PHARMACEUTICALS INC (12)
RITTER PHARMACEUTICALS INC (22)
ROCKET PHARMACEUTICALS, INC. (7)
Sage Therapeutics, Inc. (7)
Sana Biotechnology, Inc. (4)
SANGAMO THERAPEUTICS, INC (19)
Sarepta Therapeutics, Inc. (21)
Savara Inc (21)
Scholar Rock Holding Corp (2)
SEATTLE GENETICS INC (52)
SELECTA BIOSCIENCES INC (1)
SELLAS Life Sciences Group, Inc. (17)
Sensei Biotherapeutics, Inc. (3)
SERA PROGNOSTICS, INC. (3)
Seres Therapeutics, Inc. (17)
Sesen Bio, Inc. (11)
Shattuck Labs, Inc. (7)
Shuttle Pharmaceuticals Holdings, Inc. (7)
Sierra Oncology, Inc. (1)
Sigilon Therapeutics, Inc. (2)
Silverback Therapeutics, Inc. (4)
Social Capital Suvretta Holdings Corp. III (14)
SOLENO THERAPEUTICS INC (5)
Solid Biosciences Inc. (4)
SOLIGENIX, INC. (14)
SOPHIRIS BIO INC. (7)
Sorrento Therapeutics, Inc. (9)
Spectrum Pharmaceuticals, Inc. (28)
Spero Therapeutics, Inc. (5)
SPHERIX INC (14)
Spinning Eagle Acquisition Corp. (6)
Spring Bank Pharmaceuticals, Inc. (6)
SpringWorks Therapeutics, Inc. (8)
SPRUCE BIOSCIENCES, INC. (1)
SQZ Biotechnologies Co (3)
Stellar Biotechnologies, Inc. (3)
Stoke Therapeutics, Inc. (4)
Sun BioPharma, Inc. (10)
SUNESIS PHARMACEUTICALS INC (18)
Surface Oncology, Inc. (4)
SUTRO BIOPHARMA, INC. (3)
Syndax Pharmaceuticals Inc (11)
SYNLOGIC, INC. (16)
Synthetic Biologics, Inc. (15)
Syros Pharmaceuticals, Inc. (3)
T2 Biosystems, Inc. (23)
Talaris Therapeutics, Inc. (2)
Taysha Gene Therapies, Inc. (4)
TCR2 THERAPEUTICS INC. (4)
TENAX THERAPEUTICS, INC. (15)
Tenaya Therapeutics, Inc. (2)
TG THERAPEUTICS, INC. (6)
Therapeutics Acquisition Corp. (1)
Tocagen Inc (4)
Tonix Pharmaceuticals Holding Corp. (12)
Tracon Pharmaceuticals, Inc. (10)
Transcode Therapeutics, Inc. (3)
Translate Bio, Inc. (5)
TREVENA INC (3)
Trovagene, Inc. (6)
TScan Therapeutics, Inc. (6)
Turning Point Therapeutics, Inc. (1)
Twist Bioscience Corp (5)
TYME TECHNOLOGIES, INC. (4)
Tyra Biosciences, Inc. (1)
U.S. Stem Cell, Inc. (6)
Ultragenyx Pharmaceutical Inc. (28)
Unicycive Therapeutics, Inc. (5)
uniQure N.V. (9)
United Therapeutics Corp (21)
Unity Biotechnology, Inc. (5)
Unum Therapeutics Inc. (4)
UroGen Pharma Ltd. (4)
USA EQUITIES CORP. (2)
VACCINEX, INC. (5)
Vaccitech plc (3)
Vanda Pharmaceuticals Inc. (2)
Vaxart, Inc. (21)
Vaxcyte, Inc. (12)
Vaxxinity, Inc. (2)
VBI Vaccines Inc (14)
Vera Therapeutics, Inc. (1)
VERACYTE, INC. (5)
Verastem, Inc. (5)
Vericel Corp (25)
Vertex Pharmaceuticals Inc (10)
Verve Therapeutics, Inc. (3)
VICAL INC (14)
Viela Bio, Inc. (5)
Vigil Neuroscience, Inc. (3)
Viking Therapeutics, Inc. (7)
Vir Biotechnology, Inc. (23)
Virios Therapeutics, LLC (1)
VistaGen Therapeutics, Inc. (25)
VITAL THERAPIES INC (22)
VITRO DIAGNOSTICS INC (17)
Vor Biopharma Inc. (2)
Voyager Therapeutics, Inc. (7)
vTv Therapeutics Inc. (3)
Werewolf Therapeutics, Inc. (2)
WINDTREE THERAPEUTICS INC (21)
XBiotech Inc. (1)
Xencor Inc (15)
Xenetic Biosciences, Inc. (17)
Xenon Pharmaceuticals Inc. (10)
Xilio Therapeutics, Inc. (3)
XOMA Corp (21)
Y-mAbs Therapeutics, Inc. (1)
YIELD10 BIOSCIENCE, INC. (7)
Yulong Eco-Materials Ltd (2)
ZAFGEN, INC. (7)
Zai Lab Ltd (7)
Zentalis Pharmaceuticals, LLC (2)
ZIOPHARM ONCOLOGY INC (16)
Zymeworks Inc. (3)

Recent Contracts

Strategic Advisory Services Agreement between the Registrant and J. Scott Wolchko, dated as of December 31, 2024 (FATE THERAPEUTICS INC, Filed With SEC on January 6, 2025)
At-the-Market Sales Agreement dated as of January 6, 2025 between Lixte Biotechnology Holdings, Inc. and WallachBeth Capital, LLC (LIXTE BIOTECHNOLOGY HOLDINGS, INC., Filed With SEC on January 6, 2025)
Settlement and Release Agreement, dated as of January 2, 2025, by and between the Company and Paul McBarron (Cyclacel Pharmaceuticals, Inc., Filed With SEC on January 6, 2025)
Settlement and Release Agreement, dated as of January 2, 2025, by and between the Company and Spiro Rombotis (Cyclacel Pharmaceuticals, Inc., Filed With SEC on January 6, 2025)
Form of Director Settlement Agreement and Release (Cyclacel Pharmaceuticals, Inc., Filed With SEC on January 6, 2025)
LipimetiX Development, Inc. Contingent Value Rights Agreement, dated August 23, 2019, by and among Capstone Therapeutics Corp., the Shareholder Representative and Computershare... (Capstone Therapeutics Corp., Filed With SEC on December 31, 2024)
Amendment of Amended and Restated Management Fee and Transaction Fee Agreement, dated November 15, 2024, by and between Capstone Holding Corp., TotalStone, LLC, and Brookstone... (Capstone Therapeutics Corp., Filed With SEC on December 31, 2024)
Management Fee Agreement, dated March 27, 2020, by and between TotalStone, LLC and Capstone Holding Corp (Capstone Therapeutics Corp., Filed With SEC on December 31, 2024)
Brookstone Partners IAC, Inc. Amended and Restated Management Fee Agreement Dated March 1, 2020 by and between TotalStone, LLC and Brookstone Partners IAC, Inc (Capstone Therapeutics Corp., Filed With SEC on December 31, 2024)
Consent and First Amendment to the Fourth Amended and Restated Operating Agreement of TotalStone, LLC, dated March 27, 2020 and Effective as of November 26, 2021 (Capstone Therapeutics Corp., Filed With SEC on December 31, 2024)
Fourth Amended and Restated Operating Agreement of TotalStone, LLC, dated March 27, 2020 and Effective as of November 26, 2021 (Capstone Therapeutics Corp., Filed With SEC on December 31, 2024)
Placement Agency Agreement dated December 29. 2024, by and between CEL-SCI Corporation and ThinkEquity, LLC (CEL SCI CORP, Filed With SEC on December 31, 2024)
Placement Agency Agreement by and between the Company and Maxim Group LLC, dated December 27, 2024 (KBL MERGER CORP. IV, Filed With SEC on December 30, 2024)
Master Services Agreement, dated December 24, 2024, by and between the Company and Danforth Global, Inc. and Danforth Advisors, LLC (Sesen Bio, Inc., Filed With SEC on December 26, 2024)
First Amendment to Option, License and Collaboration Agreement, dated December 19, 2024, by and between the Company and Gilead Sciences, Inc (ASSEMBLY BIOSCIENCES, INC., Filed With SEC on December 19, 2024)
Master Services Agreement, dated December 13, 2024, by and between the Company and Danforth Advisors, LLC (BullFrog AI Holdings, Inc., Filed With SEC on December 17, 2024)
Contingent Value Rights Agreement, dated as of December 13, 2024, by and among, Palvella Therapeutics, Inc. (formerly Pieris Pharmaceuticals, Inc.), Shareholder Representative... (PIERIS PHARMACEUTICALS, INC., Filed With SEC on December 16, 2024)
Form of Indemnification Agreement (MiMedx Group, Inc., Filed With SEC on December 16, 2024)
Distribution Agreement, dated December 11, 2024, by and between Annovis Bio, Inc. and Oppenheimer & Co. Inc (Annovis Bio, Inc., Filed With SEC on December 11, 2024)
Business Services Agreement, dated as of July 1, 2023, by and between Kalaris Therapeutics, Inc. (formerly Theia Therapeutics, Inc.) and Samsara BioCapital, LLC (Allovir, Inc., Filed With SEC on December 9, 2024)
Sales Agreement, dated as of December 9, 2024, between Leerink Partners LLC and REGENXBIO Inc (REGENXBIO Inc., Filed With SEC on December 9, 2024)
Biologics Master Services Agreement, effective July 10, 2024, by and between WuXi Biologics (Hong Kong) Limited) and Jade Biosciences, Inc (Aerovate Therapeutics, Inc., Filed With SEC on December 3, 2024)
Amendment 3 to Development Collaboration Agreement (LIXTE BIOTECHNOLOGY HOLDINGS, INC., Filed With SEC on December 2, 2024)
Placement Agency Agreement, dated as of November 21, 2024, by and among Aptose Biosciencs Inc. and A.G.P./Alliance Global Partners, as placement agent (Aptose Biosciences Inc., Filed With SEC on November 25, 2024)
Placement Agency Agreement, dated November 18, 2024, between the Company and Maxim Group LLC (HCW Biologics Inc., Filed With SEC on November 20, 2024)
Controlled Equity OfferingSM Sales Agreement dated November 15, 2024 by and between Disc Medicine, Inc. and Cantor Fitzgerald & Co (FS Development Corp., Filed With SEC on November 15, 2024)
Settlement Agreement and Release, dated July 13, 2024, by and between the Company and Altor BioScience, LLC, NantCell, Inc., and ImmunityBio, Inc (HCW Biologics Inc., Filed With SEC on November 14, 2024)
Amendment to the Services Agreement, dated as of September 30, 2024, between the Registrant and CIC Innovation Communities, LLC (Cabaletta Bio, Inc., Filed With SEC on November 14, 2024)
Amendment to the Services Agreement, dated as of December 1, 2021, between the Registrant and CIC Innovation Communities, LLC (Cabaletta Bio, Inc., Filed With SEC on November 14, 2024)
Services Agreement, dated as of February 1, 2019, between the Registrant and CIC Innovation Communities, LLC (Cabaletta Bio, Inc., Filed With SEC on November 14, 2024)
Master Services Agreement for Viral Vector Services, dated as of September 15, 2024, between the Registrant and Henogen SRL, as part of Thermo Fisher Scientific (bluebird bio, Inc., Filed With SEC on November 14, 2024)
Term Sheet for Distribution of Deramiocel (CAP-1002) in Europe, by and between the Company and Nippon Shinyaku Co., Ltd (CAPRICOR THERAPEUTICS, INC., Filed With SEC on November 14, 2024)
Fourth Amendment to Collaboration, License and Option Agreement, dated September 16, 2024, by and between Curis, Inc. and Aurigene Discovery Technologies Limite (CURIS INC, Filed With SEC on November 14, 2024)
Third Amendment to Collaboration, License and Option Agreement, dated June 4, 2020, by and between Curis, Inc. and Aurigene Discovery Technologies Limited (CURIS INC, Filed With SEC on November 14, 2024)
Modification No. 3, dated September 27, 2024, to the ATI-RRPV Project Award Agreement No. 001, dated June 13, 2024, between Vaxart Biosciences Inc. and Advanced Technology... (Vaxart, Inc., Filed With SEC on November 13, 2024)
Second Amended and Restated Research, Collaboration & License Agreement, dated July 31, 2024, by and between the Registrant and the Trustees of the University of Pennsylvania (Passage BIO, Inc., Filed With SEC on November 13, 2024)
Research, Collaboration & License Agreement, dated July 31, 2024, by and between the Registrant and Gemma Biotherapeutics, Inc (Passage BIO, Inc., Filed With SEC on November 13, 2024)
Mutual Termination of Collaboration and License Agreement dated September 30, 2024, by and between Seres Therapeutics, Inc. and Société des Produits Nestlé S.A (Seres Therapeutics, Inc., Filed With SEC on November 13, 2024)
Mutual Termination of License Agreement dated September 30, 2024, by and between Seres Therapeutics, Inc. and NHSc Rx License GmbH (Seres Therapeutics, Inc., Filed With SEC on November 13, 2024)
Exclusive License and Collaboration Agreement, effective as of September 9, 2024, with Factor Bioscience Limited (NTN BUZZTIME INC, Filed With SEC on November 12, 2024)